Debt-to-equity of PMV Pharmaceuticals, Inc. from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PMV Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • PMV Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 9%, a 27% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

PMV Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 9% -3% -27% 30 Sep 2025
Q2 2025 9% -2% -14% 30 Jun 2025
Q1 2025 10% -1% -9.6% 31 Mar 2025
Q4 2024 11% 0% +2.3% 31 Dec 2024
Q3 2024 12% +1% +14% 30 Sep 2024
Q2 2024 11% +1% +8.4% 30 Jun 2024
Q1 2024 11% +2% +17% 31 Mar 2024
Q4 2023 11% +2% +22% 31 Dec 2023
Q3 2023 10% +2% +25% 30 Sep 2023
Q2 2023 10% +3% +36% 30 Jun 2023
Q1 2023 9% +3% +42% 31 Mar 2023
Q4 2022 9% +4% +75% 31 Dec 2022
Q3 2022 8% +5% +126% 30 Sep 2022
Q2 2022 7% +5% +190% 30 Jun 2022
Q1 2022 7% 31 Mar 2022
Q4 2021 5% 31 Dec 2021
Q3 2021 4% 30 Sep 2021
Q2 2021 3% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.